In contrast to RL cells, inhibition of neither the ERK nor AKT pathways alone was sufficient to consistently fully recover PDCD4 expression in anti-IgM-treated CLL cells, an effect that was most apparent in samples with the greatest degree of PDCD4 down-regulation. Here, PDCD4 is linked to B-cell chronic lymphocytic leukemia.